Suchergebnisse - "Ailin Zhao"

PubPharm (10)

1

Efficacy and safety of bispecific antibodies therapy for relapsed or refractory multiple myeloma: a systematic review and meta-analysis of prospective clinical trials

in: Frontiers in Immunology | 2024

von Xin Wang | Ailin Zhao | Jinbing Zhu | +1

2

Rare and complex diseases in focus: ChatGPT's role in improving diagnosis and treatment

in: Frontiers in Artificial Intelligence | 2024

von Yue Zheng | Xu Sun | Baijie Feng | +4

3

P1198: A POPULATION-BASED STUDY REVEALS THE UNIQUE CLINICAL CHARACTERISTICS AND LONG-TERM SURVIVAL OF PATIENTS WITH GRAY ZONE LYMPHOMA

in: HemaSphere | 2023

von Xin Wang | Ailin Zhao | Ting Niu

4

P1009: SKLB054, A NOVEL JAK2 INHIBITOR, POTENTLY TREATS MYELOPROLIFERATIVE NEOPLASM WITH JAK2V617F MUTATION

in: HemaSphere | 2023

von Ailin Zhao | Tao Yang | Linyu Yang | +8

5

P1201: A REAL-WORLD STUDY OF CHIDAMIDE FOR PATIENTS WITH PERIPHERAL T-CELL LYMPHOMA IN CHINA

in: HemaSphere | 2023

von Xin Wang | Ailin Zhao | Shanshan Du | +3

6

Efficacy and safety of copanlisib in relapsed/refractory B-cell non-Hodgkin lymphoma: A meta-analysis of prospective clinical trials

in: Frontiers in Immunology | 2022

von Jinjin Wang | Hui Zhou | Mingchun Mu | +5

7

Real-world landscape transition of death causes in the immunotherapy era for metastatic non-small cell lung cancer

in: Frontiers in Immunology | 2022

von Yijun Wu | Zhuoran Yao | Jianhui Zhang | +3

8

Preclinical studies of Flonoltinib Maleate, a novel JAK2/FLT3 inhibitor, in treatment of JAK2 V617F-induced myeloproliferative neoplasms

in: Blood Cancer Journal | 2022

von Mengshi Hu | Tao Yang | Linyu Yang | +13

9

Epstein-Barr Virus-Positive Lymphoma-Associated Hemophagocytic Syndrome: A Retrospective, Single-Center Study of 51 Patients

in: Frontiers in Immunology | 2022

von Ailin Zhao | Jinrong Yang | Meng Li | +7

10

Risk of Bleeding Associated With Ibrutinib in Patients With B-Cell Malignancies: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

in: Frontiers in Pharmacology | 2020

von Jinjin Wang | Ailin Zhao | Hui Zhou | +2

1
[1]